Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "iibs"

Should you invest in Inflation indexed bonds?
Financial Express

Should you invest in Inflation indexedbonds?

In June 2013 when the Reserve Bank of India auctioned its first tranche of WPI-linked Inflation Indexed Bonds (IIBs), it received strong market response as it offered a 1.44 per cent annual return over and above the headline inflation (WPI), which ... Yahoo! India, 11 hours ago
Inflation indexed bonds: Down but not out Yahoo! India, 1 day ago

Rostelecom acquires 75% stake in IIBS

Russian national operator Rostelecom plans to acquire 75 percent of the company IQmen Information Business Systems (IIBS), reports Vedomosti. The operator will use the purchased company for entering the Big Data market. Currently, Rostelecom carries ...
 Telecompaper5 days ago
Art of Jewellery

Prominent speakers to address the 3rd India International Bullion Summit

16-11-201518:40PM The third edition of India International Bullion Summit (IIBS) is all set to be held at Hotel Sahara Star, Mumbai on December 1, 2015. Shantikanta Das, Secretary, Department of Economic Affairs, Ministry of Finance, Govt of ...
 Art of Jewellery1 week ago 3rd India International Bullion Summit to be held on 1 Dec. in Mumbai  Rough Polished1 week ago

Galmed Pharmaceuticals Receives $22.00 Average Price Target from Brokerages (NASDAQ:GLMD)

Galmed Pharmaceuticals (NASDAQ:GLMD) has received a consensus rating of Buy from the six analysts that are presently covering the firm, Market Beat Ratings reports . Six investment analysts have rated the stock with a buy rating. The average 12 ...
 WKRB News14 hours ago Esperion Therapeutics Expected to Announce Earnings of -$0.59 Per Share (NASDAQ:ESPR)  American Banking News - Forex1 day ago Esperion Therapeutics Receives $63.64 Average Price Target from Brokerages (NASDAQ:ESPR)  WKRB News1 day ago Galmed Pharmaceuticals Given Consensus Recommendation of Buy by Analysts (NASDAQ:GLMD)  American Banking News - Forex3 days ago

Joint USAF/NOAA Solar Geophysical Activity Report and Forecast 27 November 2015

Status Report From: Space Weather Prediction Center (NOAA) Joint USAF/NOAA Solar Geophysical Activity Report and Forecast SDF Number 331 Issued at 2200Z on 27 Nov 2015 IA. Analysis of Solar Active Regions and Activity from 26/2100Z to ...
 SpaceRef20 hours ago

Job carnival to also feature property and exhibition booths

The fourth Iskandar Malaysia Karnival 2015 (Iskarnival) will offer 1,200 job opportunities to Johoreans during a two-day event at Puteri Harbour. Iskandar Investment Berhad (IIB) marketing and communications senior vice-president Hasnina Hafiz ... hours ago

hVIVO raises £20.5m to support portfolio development

Life sciences firm hVIVO has conditionally raised £20.5m to support its development portfolio. The company placed 9.1 million shares with existing institutional shareholders at 225.00 pence per share. hVIVO will use the net proceeds of sale to ...
 Pharmaceutical Business Review1 day ago HVIVO : Raises GBP20.5 Million To Back Portfolio Development (ALLISS)  4 Traders2 days ago hVIVO Raises GBP20.5 Million To Back Portfolio Development (ALLISS)  London South East2 days ago
Bisnis Indonesia

Drama 'Jumat Keramat' di Balai Kota

Gubernur DKI Basuki "Ahok" Tjahaja Purnama , JAKARTA--Istilah 'Jumat Keramat' tak hanya dikenal dilakukan di Komisi Pemberantasan Korupsi (KPK), tetapi di Balai Kota DKI Jakarta. Di KPK, hari Jumat selalu diidentikan dengan Jumat ...
 Bisnis Indonesia1 day ago

AVIVA : Tackling fraud- BIBA welcomes the chancellor's measures in his Autumn Statement

Release date- 26112015 - BIBA was delighted to see measures to reduce fraudulent whiplash claims in today's Autumn Statement. Steve White, BIBA CEO said; 'In our 2015 Manifesto we supported Aviva's proposal for the rehabilitation of sufferers of ...
 4 Traders1 day ago

Analysts Set PRA Health Sciences Target Price at $42.50 (NASDAQ:PRAH)

Shares of PRA Health Sciences (NASDAQ:PRAH) have been given a consensus rating of Buy by the ten ratings firms that are covering the firm, AnalystRatings.NET reports . One analyst has rated the stock with a sell recommendation, three have issued ...
 WKRB News1 day ago PRA Health Sciences Research Coverage Started at SunTrust (PRAH)  WKRB News4 days ago PRA Health Sciences Receives New Coverage from Analysts at SunTrust (PRAH)  WKRB News1 week ago PRA Health Sciences Earns Neutral Rating from Analysts at SunTrust (PRAH)  American Banking News - Forex1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less